Senior Director, Search & Evaluation Ig TA Lead
CSL, Waltham, Massachusetts, United States, 02254
Overview
CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. The role is Senior Director, Search & Evaluation Ig TA Lead, with the work location in Waltham MA, King of Prussia PA Office Maidenhead UK or Zurich Switzerland. This is a hybrid position and is onsite three days a week.
Responsibilities
Lead proactive sourcing efforts for technologies and assets across all stages of development that improve Immunoglobulin product administration, including advanced formulations, novel delivery devices, and patient-centric solutions.
Develop and execute partnering strategies for onboarding innovative technologies, creating competitive advantage and accelerating time-to-market.
Engage with external innovators, device manufacturers, and technology providers, building strong relationships and assessing strategic fit.
Drive cross-functional due diligence for selected opportunities, coordinating technical, regulatory, clinical, and commercial assessments to inform governance decisions.
Collaborate closely with BD leadership to advance high-priority opportunities through negotiation and deal close.
Represent the TA externally, leading sourcing activities at specialized conferences and fostering connections with technology networks and academic institutions.
Qualifications & Experience
12+ years in biopharma or medical device industry with experience in external innovation, technology scouting, or business development.
Advanced degree required (PhD in Pharmaceutical Sciences and/or device relevant areas).
Deep expertise in formulation science, drug delivery technologies, and device platforms relevant to Immunoglobulin products.
Proven track record of structuring and closing technology partnerships.
Strong understanding of regulatory pathways and patient-centric design considerations.
About CSL Behring CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Benefits For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
#J-18808-Ljbffr
Responsibilities
Lead proactive sourcing efforts for technologies and assets across all stages of development that improve Immunoglobulin product administration, including advanced formulations, novel delivery devices, and patient-centric solutions.
Develop and execute partnering strategies for onboarding innovative technologies, creating competitive advantage and accelerating time-to-market.
Engage with external innovators, device manufacturers, and technology providers, building strong relationships and assessing strategic fit.
Drive cross-functional due diligence for selected opportunities, coordinating technical, regulatory, clinical, and commercial assessments to inform governance decisions.
Collaborate closely with BD leadership to advance high-priority opportunities through negotiation and deal close.
Represent the TA externally, leading sourcing activities at specialized conferences and fostering connections with technology networks and academic institutions.
Qualifications & Experience
12+ years in biopharma or medical device industry with experience in external innovation, technology scouting, or business development.
Advanced degree required (PhD in Pharmaceutical Sciences and/or device relevant areas).
Deep expertise in formulation science, drug delivery technologies, and device platforms relevant to Immunoglobulin products.
Proven track record of structuring and closing technology partnerships.
Strong understanding of regulatory pathways and patient-centric design considerations.
About CSL Behring CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Benefits For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
#J-18808-Ljbffr